Webinar Archives

Over 2.5 million adults in the U.S. are diagnosed with OUD. In 2022, 12.7% of ED visits involved opioids. Yet only 25% of those who need treatment receive recommended MOUD. MOUDs are highly effective treatments that have been shown to decrease opioid use, cravings and transmission of infectious disease, and to increase retention in treatment. As the opioid epidemic continues to impact people across the U.S., the ED represents a critical access point to the health care system, supporting people with OUD by initiating MOUD, such as buprenorphine, and connecting them to low-threshold, easy-to-access care for continued treatment.

This webinar describes the evidence and regulations for methadone in emergency rooms and hospitals, including protocols for rapid methadone initiation and applying changes to the 3-day rule.

Recent attention has turned to opioid use disorder (OUD) and other substance use disorders (SUDs) as significant and growing health concerns among older adults. Biopsychosocial complications that develop with age, including medical comorbidities and cognitive impairments, contribute to some of the adverse interactions between substance misuse and the aging brain. This webinar will focus on how professionals can effectively work at the intersection of aging, mental health, and substance use, with a specific emphasis on opioid use disorder. Participants will learn practical strategies for assessing, diagnosing, treating, and supporting older clients with OUD or other SUDs, and will be empowered to offer compassionate, evidence-informed, and age-responsive care.

One in 80 adolescents and young adults aged 12-17 years (“youth”) in the United States has an opioid use disorder (OUD). Without effective treatment, youth with OUD are at risk for developing lifelong addiction and experiencing associated harms, including overdose. This presentation will review the epidemiology of substance use and overdose among US youth, review evidence-based strategies to prevent OUD, and delineate screening, treatment, harm reduction, and recovery supports to promote the health and well-being of youth with OUD.

Join Terrence D. Walton, MSW, for a webinar exploring recent research and practical guidance on integrating MOUD with specific counseling interventions to enhance medication adherence, treatment success, recovery capital, and quality of life. The presenter will use research findings and practice wisdom to explain when medication alone may be sufficient and why, for many, a combined approach is essential for thriving recovery. The webinar will also explore implications for treating those with co-occurring substance use and mental health disorders.

Rural communities face unique barriers in accessing effective treatment for opioid use disorder (OUD), including limited provider availability, stigma, and geographic isolation. This webinar will explore how medications for opioid use disorder (MOUD) can be delivered in rural settings through a combination of clinical innovation, community collaboration, and policy advocacy. Participants will explore examples of how integrated clinical services and medical intervention can improve overall treatment outcomes. The presentation will also emphasize the role of addiction professionals in addressing stigma and systemic issues in rural communities. Practical tools, real-world examples, and strategies for engaging rural communities will be shared to help participants advocate for person-centered, recovery-oriented care in their own settings.

Join our 4-session online case-based learning collaborative series focused on understanding the contaminated drug supply to treat opioid use disorder. This session will explore best practices for treating opioid use disorder and feature real-world cases provided by addiction experts. You’ll have the opportunity to apply your knowledge to practical situations. Designed for healthcare team members new to treating patients with opioid use disorder, the series aims to offer additional insights, knowledge, and confidence.

This session explores the clinical and policy landscape of providing medications for opioid use disorder (MOUD) in jails, prisons, and reentry settings. Dr. Arthur Robin Williams and Dr. Peter Treitler review recent research on the effectiveness of MOUD in reducing overdose and improving post-release treatment engagement. The session highlights key differences among methadone, buprenorphine, and extended-release naltrexone, including regulatory and logistical considerations unique to correctional environments. Learners will examine policy updates, case-based examples, and implementation strategies that support evidence-based treatment access. The session also addresses interdisciplinary collaboration, diversion concerns, and continuity of care across incarceration and reentry.

This workshop introduces participants to the harm reduction mindset and how it bridges the treatment gap between full recovery and the process within its core principles and identify some pragmatic ways to integrate harm reduction into their respective settings.

This four-session online case-based learning collaborative series is designed for healthcare professionals treating individuals with opioid use disorder (OUD). Each 1.5-hour live, virtual session will feature an educational presentation on OUD and real-world case discussions led by addiction experts, providing practical insights and actionable strategies to improve patient care. Participants will explore best practices, discuss challenges, and collaborate on solutions in an engaging, interactive format.